Stay updated on PD-L1+ NSCLC: Pembrolizumab vs Chemo Clinical Trial
Sign up to get notified when there's something new on the PD-L1+ NSCLC: Pembrolizumab vs Chemo Clinical Trial page.

Latest updates to the PD-L1+ NSCLC: Pembrolizumab vs Chemo Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3.SummaryDifference0.1%

- Check25 days agoChange DetectedPage revision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check53 days agoChange DetectedRevision: v3.4.2 is displayed, replacing the previous v3.4.1. This appears to be a backend/UI maintenance update with no visible changes to study details, eligibility criteria, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check60 days agoChange DetectedMinor version update from Revision: v3.4.0 to v3.4.1 with no visible changes to core content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check68 days agoChange DetectedShow glossary and minor copy changes (including a Revision: v3.4.0 note and capitalization tweaks) were added; these changes do not affect study data or core functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check82 days agoChange DetectedRevision label on the page updated from v3.3.3 to v3.3.4.SummaryDifference0.1%

Stay in the know with updates to PD-L1+ NSCLC: Pembrolizumab vs Chemo Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PD-L1+ NSCLC: Pembrolizumab vs Chemo Clinical Trial page.